These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9594301)

  • 1. Expression of proliferating cell nuclear antigen in Wilms' tumor.
    Chen F; Liu G; Zhang Z; Li Z; Cai W
    Chin Med J (Engl); 1997 May; 110(5):352-3. PubMed ID: 9594301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
    Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
    Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
    Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of p53 expression in Wilms' tumor in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
    Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
    Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody].
    Juszkiewicz P
    Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
    Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of proliferative activity in Wilms' tumour.
    Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME
    Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
    Wu X; Zhang Z; Cai S
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of GST-pi and PCNA expression to prognosis of advanced maxillary sinus squamous cell carcinoma].
    Guo GF; Xie RH; Yang AK; Chen ZH; Wu QL; Liu WW; Ou SM; Xia LP; Chen MY; Zhang JX
    Ai Zheng; 2005 Oct; 24(10):1267-71. PubMed ID: 16219146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of PCNA in renal pelvic and ureteral cancer].
    Kong C; Li Z; Liu T
    Zhonghua Wai Ke Za Zhi; 1996 Oct; 34(10):614-6. PubMed ID: 9590738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.